MyTVS
-
Franchise India Bureau Aug 07 2018 - 1 min readDrug major Cipla today said it has received final approval from the United States Food and Drug Administration (USFDA) for Diclofenac Sodium Topical Gel, indicated for the relief of the pain of osteoarthritis of joints such as the knees and hands. Diclofenac Sodium Topical Gel, 1 per cent is a generic therapeutic equivalent to the ...